FDA Clearance Tracker · P240014
MAGiC Ablation Catheter
Last checked: Nov 19, 2026Latest source record: Jan 5, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 5, 2026
Approved
Time to decision
633 days
Received Apr 12, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240014
- Device name
- MAGiC Ablation Catheter
- Applicant
- Stereotaxis, Inc.
- Applicant location
- Saint Louis, MO
- Received
- Apr 12, 2024
- Decided
- Jan 5, 2026
- Decision
- Approved
- Supplements
- 1 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for the MAGiC Ablation Catheter. This device is indicated for: The MAGiC Magnetic Interventional Ablation Catheter is indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, and for the creation of endocardial lesions to treat supraventricular tachycardia (e.g., macroreentrant atrial tachycardia, focal atrial tachycardia, atrioventricular nodal reentrant tachycardia, and atrioventricular reentrant tachycardia) in patients with congenital heart disease in whom vascular or target chamber access by conventional manual catheter navigation is limited due to underlying anatomic abnormalities and/or previous surgical interventions.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPB. The earliest in FDA's data is P920047, decided Oct 28, 1994.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Stereotaxis, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GenesisX RMN510(k)
K262744 · Decided Aug 27, 2026 · 24 days after receipt
Device type: System, Catheter Control, Steerable (DXX) · Cardiology
- Synchrony510(k)
K253473 · Decided Apr 1, 2026 · 173 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
K251792 · Decided Nov 6, 2025 · 148 days after receipt
Device type: System, Catheter Control, Steerable (DXX) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.